Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.


TSX:EDT - Post by User

User Avatar Image
(284)
•••
  • BlueJays9293X
Post by BlueJays9293on Aug 30, 2025 12:35pm
482 Views
Post# 36697639

Small sample of Paradigm's recent update.

Small sample of Paradigm's recent update.
Spectral Medical (EDT): Event-Driven/Episodic Pivot Opportunity as Re-Rating Process Begins
 
The set-up: Spectral Medical (EDT) announced game-changing news on August 12 (see Paradigm research note), which broke the stock out of a 5-year basing pattern. This event-driven catalyst, also known as an episodic pivot, supports a fundamental re-rating of the stock and the technical price action confirms that this process is commencingmaking for an immediately actionable entry point for investors.
 
Hallmarks of a successful episodic pivot include a high-impact catalyst, clearer path to revenue/approval, a new/expanded buyer base, resolution of uncertainty and a shift in narrative. These events will also tend to drive a high-volume gap in the stock (known as a breakaway gap), which begins a trending phase as price begins to move toward (and often beyond) the new fundamental value.
 
Why Spectral meets the criteria of an episodic pivot breakout. EDT gapped up on 2.6M shares on August 13, representing a 2,417% increase over the prior day and 13x the 30-day average volume. The stock has since held above the breakaway gap zone after several days of healthy digestion with no loss of momentum and has now recaptured the anchored VWAP from the event. The name underwent a long period of investor neglect and skepticism due to past failed septic shock treatments, but that narrative is now poised to change.
 
Why does the fundamental mispricing opportunity exist? EDT does not have strong institutional sponsorship or index/ETF representation, so the market will be less efficient in pricing in good news. This creates an opportunity for active investors, whose job it is to exploit market inefficiencies.
 
Technical set-up – base breakout targets $2.00 then $3.25. EDT has completed a structural basing pattern with the gap up through the $0.85 horizontal resistance zone, putting $2.00 then $3.25 as the next major Fibonacci targets (fundamental target sits in between at $2.70).
 
Many such cases. We highlight a handful of case studies in this note to provide visual illustration of how these events tend to play out on the charts.
<< Previous
Bullboard Posts
Next >>